Concepedia

Jean‐Baptiste Telliez

JT

Statistics

Publications

36

Citations

3.6K

H-Index

30

Active since

1992

Affiliations

Pfizer (United States)(Current)

Inflammation Research Foundation

Harvard University

Medizinische Hochschule Hannover

Women's Health Research Institute

Jean‐Baptiste Telliez is an author at Pfizer (United States) specializing in pharmacology, life sciences, and medicinal chemistry.

ORCID

Publications per year

1992–2023

36

Publications

36

The mechanism of action of tofacitinib - an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis.

Jennifer Hodge, Thomas T. Kawabata, Sriram Krishnaswami et al. · PubMed · 2016 · 372 citations

, , +17

Parsing the Interferon Transcriptional Network and Its Disease Associations

Sara Mostafavi, Hideyuki Yoshida, Devapregasan Moodley et al. · Cell · 2016 · 348 citations

, , +17

Distinct Cellular Functions of MK2

Alexey Kotlyarov, Yvonne M. Yannoni, Susann Fritz et al. · Molecular and Cellular Biology · 2002 · 235 citations

, , +15

The Mitogen-Activated Protein Kinase (MAPK)-Activated Protein Kinases MK2 and MK3 Cooperate in Stimulation of Tumor Necrosis Factor Biosynthesis and Stabilization of p38 MAPK

Natalia Ronkina, Alexey Kotlyarov, Oliver Dittrich‐Breiholz et al. · Molecular and Cellular Biology · 2006 · 219 citations

, , +16

Discovery of a JAK3-Selective Inhibitor: Functional Differentiation of JAK3-Selective Inhibition over pan-JAK or JAK1-Selective Inhibition

Jean‐Baptiste Telliez, Martin E. Dowty, Lu Wang et al. · ACS Chemical Biology · 2016 · 196 citations · Full text

, , +17

1–5 of 36